Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Inhibition of human ADAMTS-5 expressed in CHO cells using WAAG-3R as substrate in presence of 1 to 100 microM of zinc
Assay data:2 Active, 2 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by Target
Inhibition of human recombinant aggrecanase 2 after 150 mins by fluorescence plate reader
Assay data:46 Active, 46 Activity ≤ 1 µM, 47 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Inhibition of ADAMTS-5 assessed as substrate cleavage after 16 hrs by fluorescence assay
Assay data:32 Active, 23 Activity ≤ 1 µM, 32 Tested
Inhibition of human recombinant ADAMTS5 by fluorimetric assay
Assay data:2 Active, 1 Activity ≤ 1 µM, 4 Tested
An siRNA screen for human genes that are involved in human papilloma virus (HPV) E2 transcriptional repression of the E6 and E7 oncogenes
Assay data:497 Active, 21019 Tested
SummaryPubMed Citation
Inhibition of aggrecanase-2
Inhibition of aggrecanase-2 at 200 uM
Assay data:1 Tested
SummaryPubMed CitationRelated BioAssays by Target
Inhibition of ADAM-TS5 using dimethoxyfluorescein-Ser-Pro-Leu-Ala-Gln-Ala- Val-Arg-ser-Ser-Arg-Cys-fluorescein as substrate
Assay data:2 Tested
Genome-wide high-content siRNA screens for regulators of Parkin translocation in selective mitophagy (Dharmacon Library)
Assay data:826 Active, 18119 Tested
Genome-wide high-content siRNA screens for regulators of Parkin translocation in selective mitophagy (Ambion Library)
Assay data:9227 Active, 64752 Tested
Inhibition of human ADAMTS-5 expressed in CHO cells using WAAG-3R as substrate preincubated for 15 mins measured after 1 hr by FRET assay
Assay data:40 Active, 23 Activity ≤ 1 µM, 54 Tested
Competitive inhibition of human ADAMTS-5 expressed in CHO cells using WAAG-3R as substrate
Assay data:1 Active, 1 Tested
Inhibition of ADAMTS-5 by spectrophotometry
Assay data:1 Active, 19 Tested
Inhibition of human recombinant ADAMTS5 using bovine nasal cartilage aggrecan as substrate assessed as inhibition of 1772-AGEG neuropeptide formation at 1 uM incubated for 2 hrs prior to substrate addition measured after 2 hrs by Western blot analysis
Inhibition of human recombinant ADAMTS5 using bovine nasal cartilage aggrecan as substrate assessed as inhibition of 1772-AGEG neuropeptide formation incubated for 2 hrs prior to substrate addition measured after 2 hrs by Western blot analysis
Assay data:2 Active, 2 Activity ≤ 1 µM, 3 Tested
Inhibition of human recombinant ADAMTS5 expressed in HEK293 cells using Abz-TESEwSRGAIY-Dpa-KK as substrate measured for 2 hrs by fluorometric analysis
Assay data:9 Active, 5 Activity ≤ 1 µM, 9 Tested
Inhibition of human recombinant ADAMTS5 expressed in HEK293 cells using Abz-TESEwSRGAIY-Dpa-KK as substrate at 5 uM measured for 2 hrs by fluorometric analysis
Assay data:9 Tested
Inhibition of ADAMTS-5 (unknown origin)
Assay data:1 Active, 1 Activity ≤ 1 µM, 1 Tested
Non-competitive inhibition of human His-tagged ADAMTS-5 using QF-peptide as substrate by Lineweaver-Burk plot analysis
Inhibition of human His-tagged ADAMTS-5 using QF-peptide as substrate at 10 uM by FRET method
Assay data:5 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on